Foresight invests in buy-out at contract research firm
Epistem, a Manchester-based contract research organisation, has received a £2m investment from Foresight Group to support its management buy-out from genedrive plc. Dow Schofield Watts Transaction Services advised on the deal. The buy-out was led by Dr Catherine Booth, one of the original founders of Epistem and expert in epithelial stem cell biology, who will be supported by a strong executive team. … Continued